Skip to main content
Erschienen in: Diabetologia 9/2003

01.09.2003 | Article

Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance

verfasst von: E. Ferrannini, MD, A. Gastaldelli, Y. Miyazaki, M. Matsuda, M. Pettiti, A. Natali, A. Mari, R. A. DeFronzo

Erschienen in: Diabetologia | Ausgabe 9/2003

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Impaired glucose tolerance (IGT) is an insulin-resistant state and a risk factor for Type 2 diabetes. The relative roles of insulin resistance and insulin deficiency in IGT have been disputed.

Methods

In 40 IGT subjects and 63 sex-, age-, and weight-matched controls with normal glucose tolerance (NGT), we measured (i) indices of insulin sensitivity of fasting glucose production (by tracer glucose) and glucose disposal (M value on a 240 pmol·min–1·m–2 insulin clamp) and (ii) indices of beta-cell function (glucose sensitivity, rate sensitivity, and potentiation) derived from model analysis (Am J Physiol 283:E1159–E1166, 2002) of the insulin secretory response (by C-peptide deconvolution) to oral glucose.

Results

In comparison with NGT, IGT were modestly insulin resistant (M=29±2 vs 35±2 µmol·min−1·kgFFM −1, p=0.01); insulin sensitivity of glucose production also was reduced, in approximate proportion to M. Despite higher baseline insulin secretion rates, IGT was characterized by a 50% reduction in glucose sensitivity [53 (36) vs 102 (123) pmol·min−1·m–2·mM–1, median (interquartile range), p=0.001] and impaired potentiation [1.6 (0.8) vs 2.0 (1.5) units, p<0.04] of insulin release, whereas rate sensitivity [1.15 (1.15) vs 1.38 (1.28) nmol·m–2·mM–1] was not significantly reduced. Glucose sensitivity made the single largest contribution (~50%) to the observed variability of glucose tolerance.

Conclusion/interpretation

In IGT the defect in glucose sensitivity of insulin release quantitatively predominates over insulin resistance in the genesis of the reduced tolerance to oral glucose.
Literatur
1.
Zurück zum Zitat Eriksson J, Franssila-Kallunki A, Ekstrand A et al. (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337–343PubMed Eriksson J, Franssila-Kallunki A, Ekstrand A et al. (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337–343PubMed
2.
Zurück zum Zitat Saccà L, Orofino G, Petrone A, Vigorito C (1984) Differential roles of splanchnic and peripheral tissues in the pathogenesis of impaired glucose tolerance. J Clin Invest 73:1683–1687PubMed Saccà L, Orofino G, Petrone A, Vigorito C (1984) Differential roles of splanchnic and peripheral tissues in the pathogenesis of impaired glucose tolerance. J Clin Invest 73:1683–1687PubMed
3.
Zurück zum Zitat Bogardus C, Lillioja S, Howard B, Reaven G, Mott D (1984) Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 74:1238–1246PubMed Bogardus C, Lillioja S, Howard B, Reaven G, Mott D (1984) Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 74:1238–1246PubMed
4.
Zurück zum Zitat Reaven GM, Hollenbeck CB, Chen YD (1989) Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32:52–55PubMed Reaven GM, Hollenbeck CB, Chen YD (1989) Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32:52–55PubMed
5.
Zurück zum Zitat Berrish TS, Hetherington CS, Alberti KG, Walker M (1995) Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance. Diabetologia 38:699–704CrossRefPubMed Berrish TS, Hetherington CS, Alberti KG, Walker M (1995) Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance. Diabetologia 38:699–704CrossRefPubMed
6.
Zurück zum Zitat Cerasi E, Luft R (1967) Further studies on healthy subjects with low and high insulin response to glucose infusion. Acta Endocrinol (Copenh) 55:305–329 Cerasi E, Luft R (1967) Further studies on healthy subjects with low and high insulin response to glucose infusion. Acta Endocrinol (Copenh) 55:305–329
7.
Zurück zum Zitat Efendic S, Cerasi E, Luft R (1974) Quantitative study on the potentiating effect of arginine on glucose-induced insulin response in healthy, prediabetic, and diabetic subjects. Diabetes 23:161–171PubMed Efendic S, Cerasi E, Luft R (1974) Quantitative study on the potentiating effect of arginine on glucose-induced insulin response in healthy, prediabetic, and diabetic subjects. Diabetes 23:161–171PubMed
8.
Zurück zum Zitat Pimenta W, Mitrakou A, Jensen T, Yki-Jarvinen H, Daily G, Gerich J (1996) Insulin secretion and insulin sensitivity in people with impaired glucose tolerance. Diabet Med 13:S33–S36PubMed Pimenta W, Mitrakou A, Jensen T, Yki-Jarvinen H, Daily G, Gerich J (1996) Insulin secretion and insulin sensitivity in people with impaired glucose tolerance. Diabet Med 13:S33–S36PubMed
9.
Zurück zum Zitat Larsson H, Ahren B (1996) Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Diabetologia 39:1099–1107CrossRefPubMed Larsson H, Ahren B (1996) Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Diabetologia 39:1099–1107CrossRefPubMed
10.
Zurück zum Zitat Van Haeften TW, Pimenta W, Mitrakou A et al. (2002) Disturbances in beta-Cell Function in Impaired Fasting Glycemia. Diabetes 51 Suppl 1:S265–S270 Van Haeften TW, Pimenta W, Mitrakou A et al. (2002) Disturbances in beta-Cell Function in Impaired Fasting Glycemia. Diabetes 51 Suppl 1:S265–S270
11.
Zurück zum Zitat Ehrmann DA, Breda E, Cavaghan MK et al. (2002) Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance. Diabetologia 45:509–517CrossRef Ehrmann DA, Breda E, Cavaghan MK et al. (2002) Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance. Diabetologia 45:509–517CrossRef
12.
Zurück zum Zitat Ferrannini E (1998) Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 19:477–490PubMed Ferrannini E (1998) Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 19:477–490PubMed
13.
Zurück zum Zitat Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46:3–19PubMed Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46:3–19PubMed
14.
Zurück zum Zitat Polonsky KS (1999) Evolution of beta-cell dysfunction in impaired glucose tolerance and diabetes. Exp Clin Endocrinol Diabetes 107 (Suppl 4):S124–S127PubMed Polonsky KS (1999) Evolution of beta-cell dysfunction in impaired glucose tolerance and diabetes. Exp Clin Endocrinol Diabetes 107 (Suppl 4):S124–S127PubMed
15.
Zurück zum Zitat Cook D, Taborsky G (1997) ß-cell function and insulin secretion. In: Sherwin R (ed.) Ellenberg and Rifkin's diabetes mellitus: theory and practice, 5th edn. Appleton and Lange, Stamford, pp 49–73 Cook D, Taborsky G (1997) ß-cell function and insulin secretion. In: Sherwin R (ed.) Ellenberg and Rifkin's diabetes mellitus: theory and practice, 5th edn. Appleton and Lange, Stamford, pp 49–73
16.
Zurück zum Zitat Sandberg E, Ahren B, Tendler D, Carlquist M, Efendic S (1986) Potentiation of glucose-induced insulin secretion in the perfused rat pancreas by porcine GIP (gastric inhibitory polypeptide, bovine GIP, and bovine GIP(1–39). Acta Physiol Scand 127:323–326PubMed Sandberg E, Ahren B, Tendler D, Carlquist M, Efendic S (1986) Potentiation of glucose-induced insulin secretion in the perfused rat pancreas by porcine GIP (gastric inhibitory polypeptide, bovine GIP, and bovine GIP(1–39). Acta Physiol Scand 127:323–326PubMed
17.
Zurück zum Zitat Tseng CC, Zhang XY, Wolfe MM (1999) Effect of GIP and GLP-1 antagonists on insulin release in the rat. Am J Physiol 276:E1049–E1054PubMed Tseng CC, Zhang XY, Wolfe MM (1999) Effect of GIP and GLP-1 antagonists on insulin release in the rat. Am J Physiol 276:E1049–E1054PubMed
18.
Zurück zum Zitat Ferrannini E, Smith J, Cobelli C, Toffolo G, Pilo A (1985) Effect of insulin on the distribution and disposal of glucose in man. J Clin Invest 76:367–374 Ferrannini E, Smith J, Cobelli C, Toffolo G, Pilo A (1985) Effect of insulin on the distribution and disposal of glucose in man. J Clin Invest 76:367–374
19.
Zurück zum Zitat Steele R (1959) Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420–430 Steele R (1959) Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420–430
20.
Zurück zum Zitat Steele R, Wall JS, De Bodo RC, Altszuler N (1956) Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15–24 Steele R, Wall JS, De Bodo RC, Altszuler N (1956) Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15–24
21.
Zurück zum Zitat Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW, Cherrington AD (1998) Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes 47:523–529PubMed Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW, Cherrington AD (1998) Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes 47:523–529PubMed
22.
Zurück zum Zitat DeFronzo RA, Ferrannini E, Simonson DC (1989) Fasting hyperglycemia in Non-Insulin-Dependent Diabetes Mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387–395PubMed DeFronzo RA, Ferrannini E, Simonson DC (1989) Fasting hyperglycemia in Non-Insulin-Dependent Diabetes Mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387–395PubMed
23.
Zurück zum Zitat Groop LC, Bonadonna RC, DelPrato S et al. (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. J Clin Invest 84:205–213PubMed Groop LC, Bonadonna RC, DelPrato S et al. (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. J Clin Invest 84:205–213PubMed
24.
Zurück zum Zitat Ferrannini E, Cobelli C (1987) The kinetics of insulin in man. Role of the liver. Diabetes Metab Rev 3:365–397PubMed Ferrannini E, Cobelli C (1987) The kinetics of insulin in man. Role of the liver. Diabetes Metab Rev 3:365–397PubMed
25.
Zurück zum Zitat Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377PubMed Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377PubMed
26.
Zurück zum Zitat Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for the assessment of β-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159–E1166PubMed Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for the assessment of β-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159–E1166PubMed
27.
Zurück zum Zitat Mari A, Tura A, Gastaldelli A, Ferrannini E (2002) Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 51 [Suppl 1]:S221–S226 Mari A, Tura A, Gastaldelli A, Ferrannini E (2002) Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 51 [Suppl 1]:S221–S226
28.
Zurück zum Zitat Cerasi E (1981) Differential actions of glucose on insulin release: re-evaluation of a mathematical model. In: Bergman R (ed.) Quantitative physiology and mathematical modelling. Wiley, Chichester, pp 3–22 Cerasi E (1981) Differential actions of glucose on insulin release: re-evaluation of a mathematical model. In: Bergman R (ed.) Quantitative physiology and mathematical modelling. Wiley, Chichester, pp 3–22
29.
Zurück zum Zitat Licko V (1973) Threshold secretory mechanism: a model of derivative element in biological control. Bull Math Biol 35:51–58PubMed Licko V (1973) Threshold secretory mechanism: a model of derivative element in biological control. Bull Math Biol 35:51–58PubMed
30.
Zurück zum Zitat Toffolo G, De Grandi F, Cobelli C (1995) Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion. Diabetes 44:845–854PubMed Toffolo G, De Grandi F, Cobelli C (1995) Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion. Diabetes 44:845–854PubMed
31.
Zurück zum Zitat Cerasi E (1975) Potentiation of insulin release by glucose in man. Quantitative analysis of the enhancement of glucose-induced insulin secretion by pretreatment with glucose in normal subject. Acta Endocrinol (Copenh) 79:483–501 Cerasi E (1975) Potentiation of insulin release by glucose in man. Quantitative analysis of the enhancement of glucose-induced insulin secretion by pretreatment with glucose in normal subject. Acta Endocrinol (Copenh) 79:483–501
32.
Zurück zum Zitat Tseng CC, Kieffer TJ, Jarboe LA, Usdin TB, Wolfe MM (1996) Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat. J Clin Invest 98:2440–2445PubMed Tseng CC, Kieffer TJ, Jarboe LA, Usdin TB, Wolfe MM (1996) Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat. J Clin Invest 98:2440–2445PubMed
33.
Zurück zum Zitat Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA (1996) Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7–36) amide in type 2 (noninsulin-dependent) diabetic patients. J Clin Endocrinol Metab 81:327–332PubMed Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA (1996) Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7–36) amide in type 2 (noninsulin-dependent) diabetic patients. J Clin Endocrinol Metab 81:327–332PubMed
34.
Zurück zum Zitat Zimmet P, Whitehouse S, Alford F, Chisholm D (1978) The relationship of insulin response to a glucose stimulus over a wide range of glucose tolerance. Diabetologia 15:23–27PubMed Zimmet P, Whitehouse S, Alford F, Chisholm D (1978) The relationship of insulin response to a glucose stimulus over a wide range of glucose tolerance. Diabetologia 15:23–27PubMed
35.
Zurück zum Zitat Berntorp K, Lindgarde F, Malmquist J (1984) High and low insulin responders: relations to oral glucose tolerance, insulin secretion and physical fitness. Acta Med Scand 216:111–117PubMed Berntorp K, Lindgarde F, Malmquist J (1984) High and low insulin responders: relations to oral glucose tolerance, insulin secretion and physical fitness. Acta Med Scand 216:111–117PubMed
36.
Zurück zum Zitat Cretti A, Lehtovirta M, Bonora E et al. (2001) Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest 31:405–416PubMed Cretti A, Lehtovirta M, Bonora E et al. (2001) Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest 31:405–416PubMed
37.
Zurück zum Zitat Kahn S, Prigeon R, Mcculloch D et al. (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663–1672PubMed Kahn S, Prigeon R, Mcculloch D et al. (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663–1672PubMed
38.
Zurück zum Zitat Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G (1997) Insulin resistance and hypersecretion in obesity. J Clin Invest 100:1166–1173PubMed Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G (1997) Insulin resistance and hypersecretion in obesity. J Clin Invest 100:1166–1173PubMed
39.
Zurück zum Zitat Gerich JE (1998) The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 19:491–503PubMed Gerich JE (1998) The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 19:491–503PubMed
40.
Zurück zum Zitat Mitrakou A, Kelley D, Mokan M et al. (1992) Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22–29PubMed Mitrakou A, Kelley D, Mokan M et al. (1992) Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22–29PubMed
41.
Zurück zum Zitat Ferrannini E, Bjorkman O, Reichard GA, Jr et al. (1985) The disposal of an oral glucose load in healthy subjects. Diabetes 34:580–588PubMed Ferrannini E, Bjorkman O, Reichard GA, Jr et al. (1985) The disposal of an oral glucose load in healthy subjects. Diabetes 34:580–588PubMed
42.
Zurück zum Zitat Ferrannini E, Simonson DC, Katz LD et al. (1988) The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism 37:79–85PubMed Ferrannini E, Simonson DC, Katz LD et al. (1988) The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism 37:79–85PubMed
43.
Zurück zum Zitat Bonora E, Del Prato S, Bonadonna RC et al. (1992) Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 41:1151–1159PubMed Bonora E, Del Prato S, Bonadonna RC et al. (1992) Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 41:1151–1159PubMed
Metadaten
Titel
Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance
verfasst von
E. Ferrannini, MD
A. Gastaldelli
Y. Miyazaki
M. Matsuda
M. Pettiti
A. Natali
A. Mari
R. A. DeFronzo
Publikationsdatum
01.09.2003
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 9/2003
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1169-6

Weitere Artikel der Ausgabe 9/2003

Diabetologia 9/2003 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.